New Drug Combo Shows Promise Curbing Tough-to-Treat Breast C
In women with a certain form of tough-to-treat breast cancer, treatment with a combination of two drugs appeared to keep the cancer at bay longer -- from about five months to 10, a new study says.

The cancer is known as "advanced hormone receptor positive, HER 2 negative" breast cancer. Women with these tumors are often given drugs called aromatase inhibitors, which work by reducing estrogen in the body and slowing the growth of the cancer.

However, patients commonly develop resistance to aromatase inhibitor drugs, and they stop working. This is also known as endocrine therapy resistance....

https://consumer.healthday.com/cancer-information-5/breast-cancer-news-94/new-drug-combo-could-curb-tough-to-treat-breast-cancer-717592.html
S●●●●y B●●●●●v and 2 other likes this
Like
Comment
Share